RHI Magnesita India Revenue Surpasses ₹1,035 Crore in Q2 FY26
RHI Magnesita India reported record revenue of ₹1,035 crore in the second quarter of fiscal year 2026 (July-September 2025). The company saw…
Dr. Reddy’s Global Head of Biologics Resigns
Dr. Reddy’s Laboratories announced the resignation of Mr. Jayanth Sridhar, the Global Head of Biologics. Mr. Sridhar will be leaving the…
Jindal Stainless Strong Performance in Q2 & H1 FY26 Driven by Domestic Demand
Jindal Stainless reports a robust performance in Q2 & H1 FY26, driven by strong domestic demand. Sales volume increased to 648,000 MT in…
Aster DM Healthcare Monthly Report on Special Window Re-Lodgement of Shares – October 2025
Aster DM Healthcare submits its monthly report on the special window re-lodgement of shares for October 2025. As per the report, there were no…
Jindal Stainless Board Approves Subsidiary Incorporation and Q2 Results
Jindal Stainless Limited’s Board of Directors approved the incorporation of a wholly-owned subsidiary. They also reviewed and approved…
Jindal Stainless Announces Strong Financial Results for Quarter Ended September 30, 2025
Jindal Stainless announced its financial results for the quarter ended September 30, 2025, showcasing a 14.8% increase in sales volume,…
Jindal Stainless Board Approves New Subsidiary & Q2 Financials
Jindal Stainless Limited’s board has approved the incorporation of a wholly-owned subsidiary and reviewed the unaudited standalone and…
Jindal Stainless Board Approves Subsidiary Incorporation, Q2 Financials Released
Jindal Stainless’s board has approved the incorporation of a wholly-owned subsidiary. Furthermore, the company announced its unaudited…
UTI Asset Management Report on Re-lodgement of Physical Share Transfers
UTI Asset Management Company Limited has released a report on the re-lodgement of physical share transfer requests for the period from July…
Glenmark China Approves Ryaltris® for Allergic Rhinitis Treatment
Glenmark Specialty S.A. has received approval from China’s National Medical Products Administration (NMPA) for Ryaltris® Compound Nasal…